Plakoglobin (γ-catenin) is a prognostic marker in breast cancer.

被引：0
|
作者：
Buehler, H
Mahnke, E
Duvnjak, B
Schaller, G
机构：
[1] Ruhr Univ Bochum, Marienhosp Herne, Med Ctr, D-4630 Bochum, Germany
[2] Martin Luther Hosp, Berlin, Germany
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S138 / S138
页数：1
相关论文
共 50 条
  • [31] β-catenin, a novel prognostic marker for breast cancer:: Its roles in cyclin D1 expression and cancer progression
    Lin, SY
    Xia, WY
    Wang, JC
    Kwong, KY
    Spohn, B
    Wen, Y
    Pestell, RG
    Hung, MC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) : 4262 - 4266
  • [32] Manipulation of β-catenin pathway to overcome endocrine resistance in breast cancer.
    Won, Hye Sung
    Lee, Kyoung Eun
    Lee, Kyung Mee
    Nam, Eun Mi
    Mun, Yeung Chul
    Seong, Chu-Myong
    Lee, Soon-Nam
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] RECK is not an independent prognostic marker for breast cancer
    Gomes, Luciana R.
    Fujita, Andre
    Mott, Joni D.
    Soares, Fernando A.
    Labriola, Leticia
    Sogayar, Mari C.
    BMC CANCER, 2015, 15
  • [34] Prognostic Marker Expression In Microinvasive Breast Cancer
    Dimopoulos, Y.
    Sidawy, M.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 : S39 - S40
  • [35] A new prognostic marker for breast cancer metastasis
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (01) : 9 - 9
  • [36] Angiogenesis: a new prognostic marker for breast cancer
    Magennis, DP
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 1998, 55 (03) : 214 - 220
  • [37] Survivin expression as a prognostic marker for breast cancer
    Quidute, Patricia
    Quidute, Ricardo
    Perez, Matheus Moreira
    Pereira, Edimar Cristiano
    da Veiga, Glaucia Luciano
    Alves, Beatriz da Costa Aguiar
    Fonseca, Fernando Luiz Affonso
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (09):
  • [38] RECK is not an independent prognostic marker for breast cancer
    Luciana R. Gomes
    André Fujita
    Joni D. Mott
    Fernando A. Soares
    Leticia Labriola
    Mari C. Sogayar
    BMC Cancer, 15
  • [39] MGMT as a potential prognostic marker in breast cancer
    Cirullo-Neto, J.
    Carvalho, K.
    Kagohara, L.
    Olivieri, E.
    Carraro, D.
    Cunha, I.
    Vassallo, J.
    Soares, F.
    Rocha, R.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 229 - 230
  • [40] Chfr methylation as a marker of taxane sensitivity in breast cancer.
    Montero, AJ
    Shen, L
    Valero, V
    Issa, JP
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 855S - 855S
12345